Strattera

Research firm grades ADHD meds

Stimulants used to treat attention-deficit/hyperactivity disorder received an A rating for children and a B rating for adults, according to a company that evaluates the effectiveness of medications.
(MarketWatch) UPDATED 08/19/2008
View Full Story

Clinical trial: Strattera and therapy for kids with autism, ADHD

Researchers will conduct a clinical trial this fall to test the effects of Strattera and behavioral therapy for children with attention-deficit/hyperactivity disorder and autism spectrum disorders.
(Medical News Today) UPDATED 06/26/2008
View Full Story

FDA approves Strattera for long-term use

The Food and Drug Administration has approved Strattera for long-term maintenance therapy of attention-deficit/hyperactivity disorder in children and teenagers.
(Doctor's Guide) UPDATED 05/09/2008
View Full Story

Understanding the basics of ADHD meds

Attention Deficit Hyperactivity Disorder (ADHD) affects up to five percent of all children — and the use of prescription medications to treat it has tripled during the past two decades.
(Everyday Health) UPDATED 03/07/2008
View Full Story

Europe expecting much higher costs for ADHD meds

In Europe, the cost of attention-deficit/hyperactivity drugs is expected to increase by 10 times the current spending levels in the next decade, researchers say.
(Reuters) UPDATED 11/15/2007
View Full Story

Study: Strattera improves language and memory

In a small pilot study, the attention-deficit/hyperactivity medication Strattera reduced core symptoms of ADHD.
(Doctor's Guide News) UPDATED 11/21/2007
View Full Story


Navigation

Member Picks
Three vitamin supplements reflux sufferers may need
View Full Story
Chronic pain harms the brain
View Full Story
Research your meds on the Treatments tab
View Full Story
Caffeine could spell trouble for diabetics
View Full Story